SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Gives Go Ahead for Actavis’ Irinotecan Hydrochloride Injection

March 14, 2008 | 
1 min read
MORRISTOWN, NJ--(Marketwire - March 14, 2008) - Actavis Group, the international generic pharmaceuticals company, has received approval for Irinotecan Hydrochloride Injection, a cancer drug, from the US Food & Drug Administration (FDA).
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Black box mockup for cosmetics, perfume, presentation with shadows, isolated on background. Product photo for advertising package. Template for stylish cardboard packaging for goods.
Government
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac
Document checking, agreement or contract validation, financial or budget analysis, search for document files concept, businessman manager holding big magnifying glass checking document paper.
Regulatory
It’s Official: FDA Will Now Default to One Clinical Trial for Drug Applications
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
FDA
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
February 18, 2026
 · 
3 min read
 · 
Heather McKenzie
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie